Biotech Patents

Analysis, Insights and Strategies for New Challenges in Biotech Patent Practice

Monday, September 15, 2008

About

This is a crucial time for biotech patents, and it is essential that you be ready to deal with the inevitable adjustments to the practice. As such, American Conference Institute has specifically designed its annual publication from the 10th Advanced Forum on Biotech Patents to provide you with a sophisticated and comprehensive understanding of the issues you face today. In addition, our esteemed faculty guide you to the most effective practices you need to ensure protection of your biotech discovery.

Contents & Contributors

About

This is a crucial time for biotech patents, and it is essential that you be ready to deal with the inevitable adjustments to the practice. As such, American Conference Institute has specifically designed its annual publication from the 10th Advanced Forum on Biotech Patents to provide you with a sophisticated and comprehensive understanding of the issues you face today. In addition, our esteemed faculty guide you to the most effective practices you need to ensure protection of your biotech discovery.

Contents & Contributors

KEY BIOTECH CASES TO WATCH AND HOW THEY MAY IMPACT YOUR PRACTICE
Harold C. Wegner, Foley & Lardner LLC (Washington, D.C.

MAXIMIZING PRACTICE IN THE USPTO – 1600
Bill McCarthy, M.Sc., 454 Life Sciences, a subsidiary of Roche Diagnostics (Branford, CT)
Denise Kettelberger, Ph.D., Merchant & Gould P.C. (Minneapolis, MN)

NAVIGATING THE BOARD OF PATENT APPEALS AND INTERFERENCES IN LIGHT OF THE KSR DECISION
Daniel J. Pereira, Ph.D., Oblon, Spivak, McClelland, Maier & Neustadt, P.C. (Alexandria, VA)
James F. Ewing, Ph.D., Foley & Lardner LLP

USPTO RULEMAKINGS: FINAL AND PROPOSED
Michele A. Cimbala, Sterne, Kessler, Goldstein & Fox P.L.L.C (Washington, D.C.)

BIOTECH LIFE ON THE PATENT TIGHTROPE
Stephen R. Albainy-Jenei, Frost Brown Todd LLC (Cincinnati, OH)

THEY ARE COMING: PREPARING YOUR PRACTICE FOR THE INEVITABLE INSURGENCE OF FOLLOW-ON BIOLOGICS AND PREDICTION THE FUTURE OF THE BIOTECH INDUSTRY
Dr. Wolfgang Rehmann, Taylor Wessing LLP (Munich, Germany)

THE INTERNATIONAL PERSPECTIVE: PATENT PRACTICES IN THE EU – LITIGATION AND STRATEGY
Nigel Stoate, Taylor Wessing LLP (London, England)

DIFFERENCES BETWEEN THE EUROPEAN AND THE U.S. PATENT SYSTEMS
Anthony C. Tridico, Ph.D., Finnegan, Henderson, Farabow, Garrett & Dunner, LLP (Washington, D.C.)

PRACTICING BIOTECHNOLOGY ARTS: CLAIM DRAFTING STRATEGIES
Cynthia M. Soroos, Lahive & Cockfield, LLP (Boston, MA)
David Rucando, PhD, Alseres Pharmaceuticals, Inc. (Hopkinton, MA)

EX PARTE KUBIN: A CASE STUDY
Janis K. Fraser, Ph.D., Fish & Richardson P.C. (Boston, MA)
Kevin E. Noonan, Ph.D., McDonnell Boehnen Hulbert & Berghoff LLP (Chicago, IL)

STRATEGIES TO PREVENT ALLEGATIONS OF INEQUITABLE CONDUCT
Hollie L. Baker, WilmerHale (Boston, MA)
Mark I. Bowditch, Sandoz, Inc. (Princeton, NJ)